Michael Shetzline
CIK 1808509 · SVP, CMO, Head-Res&Drug · last filed 2026-03-12
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$2.40M
Companies
1
Total Filings
22
Lifetime Open-Market Net
-$1.62M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| IRWD | SVP, CMO, Head-Res&Drug | 658,037 | $3.65 | $2.40M | -$1.62M | 22 | 2026-03-12 |
Recent Filings · Page 2 of 3
22 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2023-03-01 | IRWD | Sell (S) | −19,322 | -$219.5K | EDGAR |
| 2023-01-19 | IRWD | Grant (A) | +14,663 | $0 | EDGAR |
| 2022-05-25 | IRWD | Sell (S) | −10,583 | -$121.7K | EDGAR |
| 2022-03-04 | IRWD | Grant (A) | +81,448 | $0 | EDGAR |
| 2022-03-02 | IRWD | Sell (S) | −17,607 | -$189.6K | EDGAR |
| 2022-01-21 | IRWD | Grant (A) | +29,326 | $0 | EDGAR |
| 2021-11-24 | IRWD | Sell (S) | −13,776 | -$159.5K | EDGAR |
| 2021-05-26 | IRWD | Sell (S) | −2,077 | -$25.4K | EDGAR |
| 2021-03-30 | IRWD | Grant (A) | +38,655 | $0 | EDGAR |
| 2021-03-02 | IRWD | Sell (S) | −4,439 | -$40.4K | EDGAR |
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.